New drug combo aims to curb weight gain in teens on mental health meds

NCT ID NCT05303064

Recruiting now Disease control Sponsor: Alkermes, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing if a new combination medication (OLZ/SAM) causes less weight gain than the standard drug olanzapine in children and teenagers with schizophrenia or bipolar I disorder. About 220 participants, aged 10-17, will take either the new combination or standard olanzapine for 52 weeks. The main goal is to see if the new treatment helps control the significant weight gain that is a common and serious side effect of these necessary medications.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Alkermes Investigational Site
WITHDRAWN

Kinston, North Carolina, 28504, United States
Alkermes Investigational Site
RECRUITING

Richmond, Virginia, 23220, United States
Alkermes Investigator Site
RECRUITING

Dothan, Alabama, 36303, United States
Alkermes Investigator Site
RECRUITING

Little Rock, Arkansas, 72204, United States
Alkermes Investigator Site
WITHDRAWN

Encino, California, 91316, United States
Alkermes Investigator Site
RECRUITING

Stanford, California, 94305, United States
Alkermes Investigator Site
WITHDRAWN

Upland, California, 91786, United States
Alkermes Investigator Site
WITHDRAWN

Colorado Springs, Colorado, 80910, United States
Alkermes Investigator Site
RECRUITING

Denver, Colorado, 80202, United States
Alkermes Investigator Site
WITHDRAWN

Hartford, Connecticut, 06106, United States
Alkermes Investigator Site
RECRUITING

Washington D.C., District of Columbia, 20010, United States
Alkermes Investigator Site
WITHDRAWN

Miami, Florida, 33155, United States
Alkermes Investigator Site
RECRUITING

Miami Lakes, Florida, 33016, United States
Alkermes Investigator Site
RECRUITING

Decatur, Georgia, 30030, United States
Alkermes Investigator Site
RECRUITING

Chicago, Illinois, 60611, United States
Alkermes Investigator Site
RECRUITING

Indianapolis, Indiana, 46202, United States
Alkermes Investigator Site
RECRUITING

Saint Charles, Missouri, 63304, United States
Alkermes Investigator Site
RECRUITING

Lincoln, Nebraska, 68526, United States
Alkermes Investigator Site
WITHDRAWN

Omaha, Nebraska, 68198, United States
Alkermes Investigator Site
NOT_YET_RECRUITING

Paramus, New Jersey, 07652, United States
Alkermes Investigator Site
NOT_YET_RECRUITING

New York, New York, 10016, United States
Alkermes Investigator Site
RECRUITING

Cincinnati, Ohio, 45219, United States
Alkermes Investigator Site
RECRUITING

West Chester, Ohio, 45069, United States
Alkermes Investigator Site
TERMINATED

DeSoto, Texas, 75115, United States
Alkermes Investigator Site
WITHDRAWN

Fort Worth, Texas, 76104, United States
Alkermes Investigator Site
RECRUITING

Everett, Washington, 98201, United States
Alkermes Investigator Site
RECRUITING

La Plata, Buenos Aires, 1900, Argentina
Alkermes Investigator Site
RECRUITING

La Plata, Buenos Aires, C1199ABB, Argentina
Alkermes Investigator Site
RECRUITING

Buenos Aires, C1133AAH, Argentina
Alkermes Investigator Site
RECRUITING

Córdoba, X5003DCE, Argentina
Alkermes Investigator Site
RECRUITING

Mendoza, 5500, Argentina
Alkermes Investigator Site
RECRUITING

Fortaleza, Ceará, 60430-140, Brazil
Alkermes Investigator Site
RECRUITING

Curitiba, Paraná, 80240-280, Brazil
Alkermes Investigator Site
RECRUITING

Goiânia, 74093-040, Brazil
Alkermes Investigator Site
RECRUITING

Rio de Janeiro, 22270-060, Brazil
Alkermes Investigator Site
RECRUITING

São Paulo, 01228-000, Brazil
Alkermes Investigator Site
RECRUITING

São Paulo, 05403-010, Brazil
Alkermes Investigator Site
RECRUITING

Barranquilla, 110121, Colombia
Alkermes Investigator Site
RECRUITING

Bello, 51053, Colombia
Alkermes Investigator Site
RECRUITING

Bogotá, 111166, Colombia
Alkermes Investigator Site
RECRUITING

Bogotá, 80020, Colombia
Alkermes Investigator Site
RECRUITING

Pereira, 660003, Colombia
Alkermes Investigator Site
RECRUITING

Culiacán, 80230, Mexico
Alkermes Investigator Site
RECRUITING

Estado de México, C.P. 07000, Mexico
Alkermes Investigator Site
RECRUITING

León, 37000, Mexico
Alkermes Investigator Site
RECRUITING

Monterrey, 64620, Mexico
Alkermes Investigator Site
RECRUITING

Monterrey, 64710, Mexico

Conditions

Explore the condition pages connected to this study.

BIPOLAR I DISORDER SCHIZOPHRENIA